chapter 14
Miscellaneous Neurological Disorders
The principal aim of this textbook has been to introduce simple concepts to help the ‘student of neurology’ understand the diagnostic process and to discuss the more common neurological problems encountered in everyday clinical practice. There are a number of conditions that are not common in everyday clinical practice, and yet no neurology textbook would be complete without at least some discussion of those entities. This chapter will discuss:
• assessment of patients with a depressed conscious state
• assessment of the confused or demented patient
• disorders of muscle and the neuromuscular junction
ASSESSMENT OF PATIENTS WITH A DEPRESSED CONSCIOUS STATE
The definitive text on this subject has been written by Fred Plum and Jeremy Posner in a superb text, entitled The Diagnosis of Stupor and Coma [1], that is required reading for every neurologist in training.
Essentially there are three patterns of a depressed conscious state:
1. Diffuse – consciousness is depressed in the absence of neurological signs. The main causes include:
• drugs (alcohol, opiates and sedatives)
• hypothermia (may cause coma if the temperature is less than 31°C), meningitis, encephalitis
• subarachnoid haemorrhage, acute hydrocephalus
• severe hypotension from any cause
• metabolic disturbances such as hypoxaemia, hepatic coma, hyponatraemia or hypernatraemia, hypercapnia
2. Cerebral hemisphere problems – the conscious state is depressed in the setting of a hemiparesis or hemiplegia. Conditions that produce a mass effect cause downward herniation of the brain through the tentorium and secondary compression of the brainstem. Such conditions include:
3. Diseases in the brainstem – the conscious state is depressed and there are abnormalities in the brainstem reflexes. These include:
• The airway is not obstructed.
• The patient is breathing adequately; if not, intubate them.
• The circulation, pulse and blood pressure and, if the patient is hypotensive, treat with appropriate fluids and if necessary pharmacological agents.
1. Look at the pupils. If they are pinpoint, administer naloxone. (Pontine haemorrhage and narcotic or barbiturate overdose result in pinpoint pupils.)
Neurological examination of patients in a depressed conscious state
Often patients are found unconscious and a detailed history is not possible.
• As much information as possible should be obtained from an eyewitness, if there is one, or from the person who found the patient.
• Attempt to establish when the patient was last seen well, as this helps to narrow down the time the patient may have been unconscious for.
• Have people check for empty bottles or a suicide note near where the patient was found, which indicate the possibility of a drug overdose.
• Question ambulance officers rather than rely on the ambulance report.
• Telephone relatives, neighbours or anybody who might be able to provide clues to the diagnosis.
• Ask about evidence to suggest trauma, e.g. overturned furniture, blood on the floor, syringes to suggest possible drug overdose from medications (e.g. insulin or hypoglycaemics) the patient takes.
• See if there is anything in the past medical history that may provide a clue.
The next step is to attempt to arouse the patient with verbal stimuli and, if it fails, painful stimuli (Figure 14.1). One of the most useful techniques is to pinch the skin on the medial aspect of the elbows and knees between your fingernails. A normal response is abduction of the limbs away from the painful stimulus; an abnormal response is adduction of the limbs towards the painful stimulus or extension of the limbs. Before testing the response to painful stimuli in front of the family, explain to them that it is the way to test when someone is unconscious. The family should also be warned that this technique may leave bruises.
The brainstem reflexes are then examined. The region tested is shown in brackets.
• The pupil responses – the afferent pathway is the 2nd nerve; the efferent pathway is the parasympathetic pathway on the surface of the 3rd nerve (midbrain and 3rd nerve)
• Doll’s eye reflexes – spontaneous and head movement-evoked eye movements (vertical eye movements = midbrain, horizontal eye movements = pons) (Figure 14.1)
• The corneal and nasal tickle reflexes – the afferent pathway is the 5th cranial nerve; the efferent pathway is the 7th nerve (pons) (Figure 14.1)
• The gag reflex – the afferent pathway is the 9th cranial nerve; the efferent pathway is the 10th cranial nerve (medulla)
Response to pain
Decorticate and decerebrate rigidity are two terms used to describe certain postures that may occur in the comatose patient and were formerly thought to provide localising value, although this is now in question. Decorticate rigidity refers to flexion of the elbows and wrists and supination of the arms and was said to indicate bilateral damage above (rostral) to the midbrain; decerebrate rigidity consists of extension of the elbows and wrists with pronation of the forearms indicating damage to the motor pathways in the midbrain or lower part (caudal) of the diencephalon (thalamus and hypothalamus). Similarly, the pattern of respiration is not of great localising value. For example, the cyclic breathing with periods of apnoea referred to as Cheyne–Stokes respiration can occur with bilateral hemisphere damage or metabolic suppression of the conscious state.
The pupil responses
The response of the pupils to a bright light is one of the most important aspects of the examination (see Figure 14.2). It may be necessary to use a magnifying glass to see slight reactions. The size of the pupil and the reaction to light are used to exclude or localise pathology in or affecting the midbrain and pons of the brainstem.
• Bilateral normal size (2.5–5mm) and reactive pupils:
• Unilateral dilated (> 6 mm) and non-reactive pupil + contralateral weakness:
• Compression of the ipsilateral 3rd cranial nerve with herniation due a mass lesion (tumour, haemorrhage, oedema related to a cerebral infarct) in the cerebral hemisphere
• Bilateral dilated and non-reactive pupils:
The eye movements
In normal patients the eyes may be divergent in sleep.
• Spontaneous movements of the eyes, referred to as ‘roving eyes’, exclude damage to the midbrain and pons.
• If the eyes are deviated to one side, this is either due to an ipsilateral hemisphere lesion, where the eyes look to the side of the lesion and away from the side of the paralysis, or alternatively may indicate pontine pathology, where the eyes look away from the side of the lesion and towards the side of the paralysis or hemiparesis. One exception to this rule is that with irritating hemisphere lesions the eyes may be deviated away from the side of the lesion and towards the side of the paralysis.
• Ocular bobbing indicates bilateral pontine damage, most often seen with basilar artery thrombosis. It consists of the absence of horizontal eye movements and a characteristic brisk downward movement of both eyes and then a slow upward movement to return to the normal position.
In the absence of these spontaneous ocular signs, the brainstem can be tested using the technique referred to as the oculocephalic reflex or doll’s eye test (see Figure 14.1C).
• The head is moved rapidly horizontally and then vertically while the movement of the eyes in the opposite direction to the movement of the head is observed.
• When the head is turned to the right, the eyes deviate fully left and vice versa.
• If the eye movement is full, i.e. the eyes move in the orbits to their full extent so that no sclera can be seen, this indicates that the brainstem is intact and therefore not the site of the pathology causing the impaired consciousness.
• If the eyes fail to move, this suggests damage to the ipsilateral brain stem nuclei.
• In patients with severe depression of the conscious state due to drug overdose, the oculocephalic reflexes may be abnormal and not indicate any structural damage to the brainstem. In this latter setting the pupils would usually be of normal size and react to light, something that would not occur in destructive brainstem lesions.
ASSESSMENT OF THE CONFUSED OR DEMENTED PATIENT
Confusion, delirium and dementia
CONFUSION AND DELIRIUM
Delirium is an acute and relatively sudden (developing over hours to days) decline in attention–focus, perception and cognition. The patient appears out of touch with their surroundings and is spontaneously producing evidence of this confusion, such as a lack of clear and orderly thought and behaviour, disorientation with muttering, restlessness, rambling and shouting (often offensively and continuously) with evidence of delusion and hallucinations. It is not synonymous with drowsiness and may occur without it. Other features of delirium can include: depression, memory problems, difficulty writing or finding words and disturbances of the sleep–wake cycle.
The International Classification of Diseases, 10th edition [2], defines delirium as:
• impairment of consciousness and attention;
• global disturbance of cognition (including illusions, hallucinations, delusions and disorientation);
neologisms (see Chapter 5, ‘The cerebral hemispheres and cerebellum’) or non-dominant parietal lobe lesions with patients ‘lost in space’. A quick screening examination (if the patient can cooperate) with double simultaneous stimuli in the visual fields and asking the patient to hold their arms out could detect the visual inattention and parietal drift that would alert one to focal rather than diffuse brain pathology.
DEMENTIA
Potentially treatable causes of dementia include:
• vitamin B1 or vitamin B12 deficiency
• normal pressure hydrocephalus
• chronic infections or inflammation such as syphilis, meningitis related to tuberculosis, cryptococcus, sarcoidosis and the extremely rare entity of Whipple’s disease.
It is anticipated that future discoveries will lead to even more cases of treatable dementia.
Alzheimer’s disease: Alzheimer’s disease is the commonest cause of dementia and, at the time of writing this textbook, the definitive diagnosis still requires histopathological demonstration of sufficient numbers of amyloid plaques and neurofibrillary tangles and is therefore not usually possible in life. The risk of Alzheimer’s increases with advancing age and 20–40% of patients over the age of 85 will have Alzheimer’s disease. A positive family history is not uncommon. Patients with Down syndrome (trisomy 21) have an increased risk of Alzheimer’s disease after the age of 40.
Most patients with Alzheimer’s disease will present with the insidious onset over many years of memory impairment, particularly short-term memory. As cognitive function declines the patient develops increasing difficulties with daily activities and it is this difficulty that differentiates mild cognitive impairment from true dementia. A reversal of the sleep cycle with patients sleeping during the day and wandering at night is not uncommon. Some patients with Alzheimer’s disease are unaware of their cognitive impairment and it is concerned relatives that urge them to seek medical attention. Patients may cope well in their home environment, but often the dementia is unmasked when they are admitted to hospital or when they travel and are placed in an unfamiliar environment. As the disease relentlessly progresses, patients become lost when they go for walks or when they are driving, and they have difficulty with finances, housekeeping, shopping and following instructions. Leaving the stove on is a common complaint. Walking becomes difficult and patients may develop a characteristic disorder of gait referred to as the apraxic gait (see Chapter 13, ‘Abnormal movements and difficulty walking due to central nervous system problems’). Language function deteriorates with difficulty naming objects, comprehension and then subsequently the development of aphasia. In advanced Alzheimer’s patients are no longer able to care for themselves in terms of dressing, bathing and feeding and eventually lose control of bladder and bowels.
Depression can present with many of the clinical features of dementia that resolve with treatment of the depression and this is referred to as ‘pseudodementia’. It is the intellectual impairment in patients with a primary psychiatric disorder, in which the features of intellectual abnormality resemble, at least in part, those of a neuropathologically induced cognitive deficit. These patients often complain of memory disturbance and yet are often able to recant the history of their ‘cognitive decline’ without much difficulty. The correct diagnosis may only reveal itself when the patient improves with treatment for depression. Reynolds et al [6] in a small study found that significantly greater pretreatment early morning awakening, higher ratings of psychological anxiety and more severe impairment of libido were features of pseudodementia whereas patients with dementia showed significantly more disorientation to time, greater difficulty finding their way about familiar streets or indoors and more impairment with dressing.
In very rare instances dementia may begin with focal neurological deficits [7–10] and a number of syndromes have been identified, such as posterior cortical atrophy (PCA), corticobasal syndrome (CBS), behavioural variant frontotemporal dementia (bvFTD), progressive non-fluent aphasia (PNFA) (or a mixed aphasia) and semantic dementia (SD). In some instances these patients will have the pathological features of Alzheimer’s disease. These focal syndromes may remain pure for many years before the subsequent appearance of other signs of dementia. The underlying neuropathology does not uniquely associate the clinical syndromes with distinctive patterns of pathological markers. A detailed discussion of these entities is beyond the scope of this textbook [7, 9, 10].
Rapidly progressive dementia (RPD): Rapidly progressive dementias can develop subacutely over months, weeks or even days and be quickly fatal. Prion disease (Creutzfeldt–Jakob disease) is the commonest cause, but some cases of frontotemporal dementia (FTD), corticobasal degeneration (CBD), Alzheimer’s disease, dementia with Lewy bodies (DLB) and progressive supranuclear palsy may sometimes present in a fulminant form with death occurring in less than 3 years [11].
Forgetfulness or early dementia: Forgetfulness or absent-mindedness is a feature of the ageing process. Most patients over the age of 70 complain of problems with memory and many patients seek medical attention concerned about the possibility of dementia. It can be very difficult in the early stages to differentiate between these two processes [12]. Episodic memory loss precedes widespread cognitive decline in early AD [13].
DISORDERS OF MUSCLE AND THE NEUROMUSCULAR JUNCTION
Diseases of muscle and conditions affecting the neuromuscular junction are very rare. For example, the prevalence of inflammatory muscle disease is estimated to be 1 in 100,000 and of myasthenia gravis is 8 in 100,000. A complete discussion of all disorders of muscle is well beyond the scope of this text and interested readers will find many excellent reviews, textbooks and websites [15–18].
• Muscle pain or myalgia, apart from (therapeutic) drug-induced muscle pain, is rare in muscle diseases and more often relates to rheumatological, psychiatric or orthopaedic disorders, although it may occur in patients with congenital or endocrine myopathies and myositis. It is important to question about the use of prescription and non-prescription medications when a patient presents with muscle pain.
For a recent review on drug-induced myopathies, refer to Klopstock [19].
• Fatigue is also a very non-specific symptom. Patients with depression, for example, often complain of fatigue; however, fatigue in the form of exercise intolerance may point to involvement of the neuromuscular junction with conditions such as myasthenia gravis and the Lambert–Eaton syndrome. Fatigue is also a prominent symptom in patients with motor neuron disease.
• Muscle cramps are seen with hyponatraemia, renal failure, hypothyroidism and many other conditions that affect peripheral nerves.
• Myotonia is the inability to relax a muscle after forced voluntary contraction, for example gripping an object with the hands. It is seen in some of the hereditary disorders of muscle such as myotonic dystrophy and Thompson’s disease as well as acquired disorders such as neuromyotonia (Isaac’s syndrome).
There are many approaches to patients with suspected muscle disease; one is shown in Figure 14.3.
FIGURE 14.3 An approach to patients with suspected muscle disease
Note: The uncommon diseases are in italics.
∗A ‘negative’ family history does not exclude inherited disorders of muscle. ‘Other’ pattern refers to patterns of weakness other than proximal or distal, for example fascioscapulohumeral.
ICU = intensive care unit; LGMD = limb-girdle muscular dystrophy
1. The initial step is to establish if there is a family history, as many diseases of muscle, such as the muscular dystrophies and the congenital, metabolic and mitochondrial myopathies, are inherited disorders of muscle and there will be another member of the family affected. It is important to remember that a negative family history does not exclude hereditary disorders of muscle. Some patients are so mildly affected that they are not aware of the problem or have not sought medical attention. This is not uncommon in patients with muscular dystrophy.
2. The age of onset can provide another clue, e.g. congenital myopathies may be present at birth, the muscular dystrophies often develop in the first few years of life and inclusion body myositis is predominantly seen in elderly patients.
3. Consider the rapidity of onset of the weakness. Many disorders of muscle, particularly the inherited disorders of muscle, develop gradually over many, many years; most of the acquired disorders of muscle, for example the inflammatory myopathies, on the other hand progress rapidly over months. Patients with congenital myopathies may not progress at all. Fluctuating weakness suggests disorders of the neuromuscular junction, such as myasthenia gravis and the Lambert–Eaton syndrome. Recurrent attacks of weakness are a feature of the periodic paralyses and certain glycolytic pathway disorders.
4. Define the pattern of weakness. Many conditions of muscle have been labelled according to the pattern of weakness, for example limb-girdle muscular dystrophy or fascioscapulohumeral dystrophy. This may be less important in the future. As the underlying genetic bases for the muscle diseases are defined, it is increasingly apparent that there is great variability in the phenotypic expression (the pattern of weakness), reflecting the severity of the underlying the genetic defect. For example, with mutations in the dysferlin gene, patients can present with the pattern of a limb-girdle muscular dystrophy, a distal anterior compartment myopathy or the classic Miyoshi myopathy with multifocal weakness and wasting [20]. The term ‘dysferlin deficient muscular dystrophy’ has replaced the term ‘Miyoshi myopathy’. The classification of the limb-girdle dystrophies continues to be revised on the basis of the elucidation of the underlying protein and genetic abnormalities [21]. In everyday clinical practice, other than a proximal muscle weakness, the ‘proximal myopathy’ that is probably the most common pattern and distal weakness in the forearms, most of the other disorders of muscle are extremely rare.
5. Look for associated phenomena that may help differentiate one condition from another.
• Duchenne and Becker muscular dystrophy